Every Form 4 that Exelon Corporation (EXC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow EXC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EXC filings page.
Exelon Corp director Matthew C. Rogers received a grant of deferred phantom share equivalents as part of his compensation. On the transaction date, he acquired 778 deferred phantom share equivalents tied to Exelon common stock at a reference price of $46.62 per share. These units are held in his Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis when his board service ends. After this grant and dividend-related accruals, his balance in this plan totals 1,524 phantom share equivalents, including 7 units added through automatic dividend reinvestment.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie received a grant of 5 deferred phantom share equivalents tied to Exelon common stock. These were awarded at a reference price of $46.62 per equivalent and increase her deferred phantom share balance to 3,896 equivalents.
The phantom share equivalents are held in an Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after her service on the board ends. The balance includes 35 additional equivalents that accrued automatically through dividend reinvestment, highlighting this as compensation and deferral activity rather than open-market trading.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers received a compensation grant of 442 deferred phantom share equivalents of Exelon common stock at a reference price of $46.62 per equivalent. This increased her balance in the Exelon stock fund account under a multi-fund, non-qualified deferred compensation plan to 10,547 phantom share equivalents.
These phantom share equivalents will be settled for cash on a 1-for-1 basis when her service on the board of directors ends. The balance includes 91 additional phantom share equivalents that accrued automatically through dividend reinvestment in the plan.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director William P. Bowers reported a compensation-related award of deferred phantom share equivalents tied to Exelon common stock. He received 925 phantom share equivalents at a reference value of $46.62 per share, increasing his balance in the Exelon stock fund account to 21,266 equivalents.
These phantom share equivalents are part of a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after his service on the board ends. The reported balance also reflects 183 additional phantom share equivalents that accrued automatically through dividend reinvestment, indicating this is a cash-settled, deferred arrangement rather than an open-market stock purchase or sale.
Segedi Bryan K reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Bryan K. Segedi received a grant of 3,720 2026 Directors Restricted Stock Units (RSUs). These RSUs were awarded at no cash cost as part of the Exelon Long-term Incentive Plan.
The RSUs will fully vest and be settled on a 1-for-1 basis into Exelon common stock on April 28, 2027. Additional stock units will accrue through dividend reinvestment and will vest at the same time as the underlying award. Following this grant, Segedi holds 3,720 RSUs linked to Exelon common stock.
Exelon Corp director Matthew C. Rogers received an annual equity award of 3,720 restricted stock units for 2026 board service. These 2026 Directors Restricted Stock Units were granted at a $0.00 exercise price under the Exelon Long-term Incentive Plan and will fully vest and be settled in Exelon common shares on a 1-for-1 basis on April 28, 2027. The award will accumulate additional stock units through dividend reinvestment that vest with the underlying grant.
The filing also notes 739 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when Rogers’ service on Exelon’s board ends, rather than through open-market stock transactions.
RICHO ANNA reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Anna Richo reported a compensation-related equity grant and updated deferred holdings. She received 3,720 "2026 Directors Restricted Stock Units" on April 28, 2026, which are scheduled to fully vest and be settled in Exelon common stock on a 1-for-1 basis on April 28, 2027 under the Exelon Long-term Incentive Plan.
The filing also shows 7,930 deferred phantom share equivalents in a non-qualified deferred compensation plan, each linked 1-for-1 to Exelon common stock and payable in cash after her service on the board ends. No open-market buys or sells are reported in this filing.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported an annual equity award and deferred compensation holdings. On April 28, 2026, she received 3,720 2026 Directors Restricted Stock Units under Exelon’s Long-term Incentive Plan, vesting and settling in common stock on a 1-for-1 basis in 2027. She also holds 3,855 deferred phantom share equivalents in a non-qualified deferred compensation plan, payable in cash on a 1-for-1 basis after her service on the board ends.
Jojo Linda P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Linda P. Jojo received a grant of restricted stock units under the Exelon Long-term Incentive Plan. On April 28, 2026, she was awarded 3,720 2026 Directors Restricted Stock Units at a price of $0.00 per unit as compensation, not an open-market purchase.
The RSUs are scheduled to fully vest on April 28, 2027 and will be settled in an equal number of Exelon common shares on a 1-for-1 basis. The award will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the underlying grant.
Exelon Corp director David G. DeWalt received an annual award of 3,720 restricted stock units (RSUs) designated as 2026 Directors Restricted Stock Units. These RSUs were granted as compensation under the Exelon Long-term Incentive Plan.
The award will fully vest on April 28, 2027 and then be settled in Exelon common stock on a 1-for-1 basis, meaning each unit converts into one share. The RSUs will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the original award. Following this grant, DeWalt holds 3,720 of these RSUs directly.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers reported routine equity-based compensation and existing deferred balances. On 2026-04-28, she received a grant of 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will fully vest and be settled in Exelon common stock on a 1-for-1 basis on 2027-04-28, and will also accrue additional stock units through dividend reinvestment that vest with the underlying award.
Rodgers also reported 10,013 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when her service on the board ends. No open-market purchases or sales were reported in this filing.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director William P. Bowers received a compensation-related equity award and reported existing deferred units. On 2026-04-28, he was granted 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will vest and be settled in Exelon common stock on a 1-for-1 basis and will accrue additional stock units through dividend reinvestment.
He also reported 20,158 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. According to the plan, these phantom share equivalents will be settled in cash on a 1-for-1 basis when his service on the board ends.
Exelon Corp director Bryan K. Segedi received an award of 878 common stock deferred stock units at $49.82 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. Following this grant, he holds 9,451 deferred stock units indirectly, including 72 units acquired through automatic dividend reinvestment.
Rogers Matthew C reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director Matthew C. Rogers reported compensation-related equity awards. He received 739 deferred phantom share equivalents tied to Exelon common stock at $49.02 per equivalent, bringing his balance in this derivative instrument to 739 units, with 98 of these obtained through automatic dividend reinvestment.
He was also granted 878 shares of common stock in the form of deferred stock units at $49.82 per unit, held indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan, increasing that plan balance to 12,554 units. The phantom share equivalents are part of a non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after his service on the board ends.
Exelon Corp director Anna Richo reported a grant of 878 common stock deferred stock units valued at $49.82 per unit. These units were credited under the Exelon Corp. Directors Deferred Stock Unit Plan and are held as an indirect interest, bringing her deferred stock unit balance to 11,337 units, including 87 acquired through automatic dividend reinvestment.
Separately, she holds 7,930 deferred phantom share equivalents in an Exelon stock fund within a multi-fund, non-qualified deferred compensation plan. According to the disclosure, these phantom share equivalents, which include 66 accrued through automatic dividend reinvestment, will be settled for cash on a 1-for-1 basis with Exelon common stock when her service on the board ends.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported routine equity-based compensation awards. She received 5 deferred phantom share equivalents tied to Exelon common stock at $49.02 per equivalent, bringing her phantom share balance to 3,855 equivalents. She was also credited with 878 common stock deferred stock units at $49.82 per unit through the Exelon Corp Directors Deferred Stock Unit Plan, increasing that plan balance to 12,554 units. Separately, she holds 7,246 shares of common stock directly, with both the share and phantom equivalent balances including amounts added through automatic dividend reinvestment. The phantom share equivalents are part of a non-qualified deferred compensation plan and will be settled for cash on a one-for-one basis when her board service ends.
Exelon Corp director Linda P. Jojo received a grant of 878 common stock deferred stock units on March 31, 2026, credited under the Exelon Corp Directors Deferred Stock Unit Plan. The units were valued at $49.82 per share. After this award, her indirect holdings total 56,036 deferred stock units, including 461 additional units acquired through automatic dividend reinvestment.
Exelon Corp director David G. DeWalt received a grant of 878 deferred stock units of common stock credited under the Exelon Corp. Directors Deferred Stock Unit Plan on March 31, 2026. These are indirect holdings used for director compensation rather than a market purchase or sale.
After this award, his indirect balance under the plan totaled 4,009 deferred stock units, which includes 26 additional units acquired through automatic dividend reinvestment.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers received additional deferred equity-based awards on March 31, 2026. She was granted 421 deferred phantom share equivalents tied to Exelon common stock at a reference price of $49.02, bringing her balance in this account to 10,013 phantom share equivalents.
She also received 878 deferred stock units of Exelon common stock at a reference price of $49.82 through the Exelon Corp. Directors Deferred Stock Unit Plan, increasing that indirect holding to 25,723 units. Footnotes note additional shares and phantom share equivalents have accumulated over time through automatic dividend reinvestment, and phantom share equivalents will be settled for cash on a 1-for-1 basis after her board service ends.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director William P. Bowers reported equity-based compensation awards rather than open-market trades. He received 880 deferred phantom share equivalents tied to Exelon common stock at a reference price of $49.02 each, bringing his phantom share balance to 20,158 equivalents.
He was also credited with 878 common stock deferred stock units at a reference price of $49.82 through the Exelon Corp Directors Deferred Stock Unit Plan, increasing that indirect holding to 19,978 units. A separate line shows a direct holding of 4,500 common shares. Footnotes note additional shares and phantom equivalents accrued through automatic dividend reinvestment and that phantom share equivalents are settled for cash after his board service ends.
Exelon Corporation executive Timothy George Peterson, EVP Chief Customer & Technology Officer, reported a new equity award. On February 2, 2026, he received 11,274 restricted stock units (RSUs) under Exelon’s Long Term Incentive Plan. The RSUs vest in one-third increments at January or February meetings of the Talent Management and Compensation Committee and earn additional RSUs through automatic dividend reinvestment. After this grant, Peterson also directly holds 199 shares of Exelon common stock.
Exelon Corporation senior vice president Robert A. Kleczynski reported multiple stock-based compensation transactions dated 02/02/2026. He converted 2023, 2024 and 2025 restricted stock units and 2023–2025 performance shares into a total of 12,287 shares of Exelon common stock at a conversion price of $0 per share.
On the same date, he received new grants of 5,673 restricted stock units and 7,019 performance shares, both at a stated price of $0. To cover taxes, 3,768 shares were withheld at $43.91 per share, and 4,963 shares of common stock were disposed of at $43.91 per share. After these transactions, he directly held 44,681 shares of Exelon common stock and 1,798 deferred phantom share equivalents.
Exelon Executive Vice President and CFO Jeanne M. Jones reported several equity compensation transactions on February 2, 2026. She exercised previously granted restricted stock units and performance shares into common stock, including 5,197 2023 RSUs, 6,485 2024 RSUs, 7,031 2025 RSUs, and 24,701 2023–2025 performance shares.
Jones also received new awards of 18,789 2026 restricted stock units and 24,701 2023–2025 performance shares at no cost. To cover tax obligations, 16,051 common shares were withheld at $43.91 per share, and she separately disposed of 7,154 common shares at $43.91 per share, ending with direct ownership of 60,802 Exelon common shares.
Exelon Corporation executive Michael Innocenzo, EVP & Chief Operating Officer, reported multiple equity compensation transactions dated 02/02/2026. Several batches of restricted stock units and performance shares were converted into Exelon common stock, increasing his directly held common shares to 86,802, plus 2,835 shares in an employee stock purchase plan.
He also received a new grant of 20,668 2026 restricted stock units and held 2,274 deferred phantom share equivalents as of 12/31/2025. To cover tax obligations on vesting, 9,547 shares of common stock were withheld at $43.91 per share, and he disposed of an additional 7,199 shares at the same price.
Exelon EVP Colette Honorable reported equity compensation activity dated 02/02/2026. She converted 2024 and 2025 restricted stock units into 3,872 and 4,781 shares of Exelon common stock, respectively, and disposed of 3,184 common shares at $43.91 per share. After these transactions, she directly owned 7,740 common shares. She also received a new 2026 restricted stock unit award covering 12,777 shares, which accrues additional units through automatic dividend reinvestment and vests in annual thirds under Exelon’s long-term incentive plan.
Exelon Corp President & CEO Calvin Butler Jr. reported multiple equity compensation events on February 2, 2026. Previously granted restricted stock units and performance shares converted into 198,151 shares of common stock, while new awards of 88,306 restricted stock units and 111,956 performance shares were granted under Exelon’s long-term incentive plan.
To cover taxes on these vestings, 82,268 shares of common stock were withheld at $43.91 per share. Butler also disposed of 31,793 common shares at $43.91 per share. After these transactions, he directly owned 262,584 Exelon common shares, plus 4,499 common shares in a 401(k) plan as of December 31, 2025.
Insider acquisition of deferred stock units by an Exelon director. Bryan K. Segedi, listed as a director, acquired 950 deferred stock units on 09/30/2025 at an indicated price of $43.43 per unit. Following the transaction he is reported to beneficially own 7,492 units indirectly under the Exelon Corp. Directors Deferred Stock Unit Plan; that balance includes 60 shares added through automatic dividend reinvestment. The filing reports the transaction as an acquisition of non-derivative deferred stock units as part of director compensation and records the holding as indirect ownership through the directors' plan.
Matthew C. Rogers, a director of Exelon Corp (EXC), received 950 deferred stock units on 09/30/2025 at a reported price of $43.43 each. The filing shows these units are held indirectly under the Exelon Corp. Directors Deferred Stock Unit Plan and increase Mr. Rogers' total reported balance to 10,542 units. The balance includes 88 shares acquired via automatic dividend reinvestment. The Form 4 was signed by David T. Skinner as attorney-in-fact on 10/01/2025.
Anna Richo, a director of Exelon Corp (EXC), received equity-based deferred compensation tied to Exelon common stock. On 09/30/2025 she was credited 950 deferred stock units at a reported price of $43.43, bringing her total indirect holdings in deferred stock units to 9,346 (that total includes 77 shares from dividend reinvestment). On the same date she was credited 694 phantom share equivalents694 underlying common shares$45.017,082 (including 55 accrued on the ex-dividend date). The transactions were reported on a Form 4 by an attorney-in-fact on behalf of the reporting person.
Insider acquisition and holding summary: Exelon director Linda P Jojo acquired 950 deferred stock units on 09/30/2025 at a reported price of $43.43 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. After the reported transaction, Ms. Jojo beneficially owns 53,270 shares (held indirectly). The filing notes that the balance includes 477 additional shares acquired through automatic dividend reinvestment. The Form 4 was submitted by David T. Skinner as attorney-in-fact and dated 10/01/2025.
David G. DeWalt, an Exelon Corp. director, reported an acquisition of 950 deferred stock units on 09/30/2025 at a reported price of $43.43 per unit. Following the transaction, Mr. DeWalt beneficially owned 2,145 units indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan. The reported balance includes 11 additional shares acquired via automatic dividend reinvestment. The Form 4 was executed by David T. Skinner as attorney-in-fact and dated 10/01/2025.
Exelon Corp (EXC) director William P. Bowers reported transactions dated 09/30/2025. The filing shows he acquired 950 deferred stock units at $43.43 and acquired 1,805 phantom share equivalents in a non‑qualified deferred compensation plan valued at $45.01 per underlying share. He also disposed of 4,500 shares of common stock. Following these transactions he beneficially owned 17,838 shares indirectly (including 154 shares from dividend reinvestment) and directly held 17,097 phantom equivalents (including 133 credited on the ex‑dividend date). The phantom equivalents will be settled in cash upon termination of board service.